Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Kazutake Yoshizawa
Predictive Factors for 24 Weeks Sustained Virologic Response (SVR24) and Viral Relapse in Patients Treated With Simeprevir Plus Peginterferon and Ribavirin
Hepatology International
Hepatology
Related publications
Characterization of Nonrapid Virologic Response Patients Infected With HCV Genotype 1 Who May Relapse After Standard Therapy With Peginterferon Plus Ribavirin
Journal of Viral Hepatitis
Virology
Hepatology
Infectious Diseases
Low Rates of Sustained Virologic Response With Peginterferon Plus Ribavirin for Chronic Hepatitis C Virus Infection in HIV Infected Patients in Rio De Janeiro, Brazil
PLoS ONE
Multidisciplinary
An Hepatitis C Virus (HCV)/HIV Co-Infected Patient Who Developed Severe Hepatitis During Chronic HCV Infection: Sustained Viral Response With Simeprevir Plus Peginterferon-Alpha and Ribavirin
Internal Medicine
Internal Medicine
Medicine
Randomized Trial of Peginterferon Alfa-2b and Ribavirin for 48 or 72 Weeks in Patients With Hepatitis C Virus Genotype 1 and Slow Virologic Response
Hepatology
Medicine
Hepatology
Sustained Virologic Response and IL28B Single-Nucleotide Polymorphisms in Patients With Chronic Hepatitis C Treated With Pegylated Interferon Alfa and Ribavirin.
Acta Biochimica Polonica
Biochemistry
Genetics
Molecular Biology
Ombitasvir/Paritaprevir/Ritonavir Plus Ribavirin for 24 Weeks in Patients With HCV GT4 and Compensated Cirrhosis (AGATE-I Part II)
Health Science Reports
Prediction of Sustained Virological Response to Telaprevir/Simeprevir-Based Triple Therapy in Patients With Genotype 1 Hepatitis C Virus Using Super-Early Viral Response Within 2 Weeks
Journal of Liver
Peginterferon Alfa-2a Is Associated With Elevations in Alanine Aminotransferase at the End of Treatment in Chronic Hepatitis C Patients With Sustained Virologic Response
PLoS ONE
Multidisciplinary
Incidence of and Risk Factors for Thyroid Dysfunction During Peginterferon Α and Ribavirin Treatment in Patients With Chronic Hepatitis C
Korean Journal of Internal Medicine
Internal Medicine
